Briefing Information for the May 24, 2017 Meeting of the Oncologic Drugs Advisory Committee (ODAC)
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance.
FDA - Morning Session
- FDA Briefing Document Oncologic Drugs Advisory Committee Meeting May 24, 2017 (AM Session)
- Errata to the FDA Briefing Information for the May 24, 2017 Meeting of the Oncologic Drugs Advisory Committee (AM Session)
Puma Biotechnology, Inc.
FDA - AfternoonSession
- FDA Briefing Information for the May 24, 2017 Meeting of the Oncologic Drugs Advisory Committee (PM Session)
- Errata to the FDA Briefing Information for the May 24, 2017 Meeting of the Oncologic Drugs Advisory Committee (PM Session)